Home
Storia in 1 fonti
How Timely, Precise Lab Data Drive Decisions from Discovery to Post-Marketing Surveillance
How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how de-identified laboratory data supports clinical development, commercial strategy, patient insights, and post-market evaluation. | How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how de-identified laboratory data supports clinical development, commercial strategy, patient insights, and post-market evaluation.
Raccontata da
fiercepharma.com
- ·
BMS taps Anthropic’s Claude for enterprise-wide AI adoption to speed R&D, global workflows
Bristol Myers Squibb is the latest large pharma company to be making a major bet on artificial intelligence,
- ·
Fierce Pharma Asia—Merck-Kelun ADC’s triple wins; Tools in China licensing deals; Takeda’s $885M antitrust loss
Merck & Co. and Kelun-Biotech's sac-TMT is on fire this week with details or first reports of three positive phase 3 trials. | Merck & Co. and Kelun-Biotech's sac-TMT is on fire…
- ·
How Timely, Precise Lab Data Drive Decisions from Discovery to Post-Marketing Surveillance
How can timely, precise lab data improve decision-making across the medicine lifecycle? Download this whitepaper to explore how de-identified laboratory data supports clinical…